Cancer screening study for HIV-infected patients by blood transfusion

A study on cancer screening on HIV-infected patients by blood transfusion

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT1032220397

Enrollment

130

Registered

2022-10-20

Start date

2022-10-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HIV infection HIV-1, cancer

Interventions

Chest and abdominal CT scan including thyroid and prostate,gastric endoscopy,head MRI scan stool occult blood,tumor markers of AFP,CEA,PSA( men), CA125(female) ,and Retrotransposon are perfor med tw

D014056, D016099

CT scan, Gastrointestinal endoscopy

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.HIV infected person caused by transfusions of HIV-tainted blood products 2.A written informed consent was obtained

Exclusion criteria

Exclusion criteria: 1.Severe underlying and/or active AIDS disease that need to be treated 2.Patients who have difficulty to participate in this study due to psychological disease 3.Patients who are judged to be inappropriate in participation by the attending docter

Design outcomes

Primary

Measure	Time frame
To demonstrate incidence(per 100 person-year) of the NADM among HIV infected patients by blood transfusion	—

Secondary

Measure	Time frame
Identification of the risk factors for NADM among HIV infected patients by blood transfusion	—

Contacts

Public ContactHaruka Uemura

National Center for Global Health and Medicine

huemura@acc.ncgm.go.jp+81-3-3202-7181

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026